|
TMED7-TICAM2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.026500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.983100E-04 |
| Normal-vs-Stage2 |
7.239200E-01 |
| Normal-vs-Stage3 |
6.751200E-01 |
| Normal-vs-Stage4 |
1.237200E-01 |
| Stage1-vs-Stage2 |
1.056840E-01 |
| Stage1-vs-Stage3 |
3.237700E-02 |
| Stage1-vs-Stage4 |
3.754300E-02 |
| Stage2-vs-Stage3 |
9.734200E-01 |
| Stage2-vs-Stage4 |
1.487640E-01 |
| Stage3-vs-Stage4 |
1.780160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.231660E-02 |
| Normal-vs-AfricanAmerican |
2.388200E-01 |
| Normal-vs-Asian |
1.759350E-01 |
| Caucasian-vs-AfricanAmerican |
4.384200E-01 |
| Caucasian-vs-Asian |
8.689800E-02 |
| AfricanAmerican-vs-Asian |
2.001000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.316870E-03 |
| Normal-vs-Female |
7.100800E-01 |
| Male-vs-Female |
1.900450E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.592600E-01 |
| Normal-vs-Extreme_Weight |
1.618710E-04 |
| Normal-vs-Obese |
6.912200E-01 |
| Normal-vs-Extreme_Obese |
2.993500E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.688200E-02 |
| Normal_Weight-vs-Obese |
5.938000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.170800E-01 |
| Extreme_Weight-vs-Obese |
4.065000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.869400E-01 |
| Obese-vs-Extreme_Obese |
2.273000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.589000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.845000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.004100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.000530E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.430200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.207650E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.713500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.352200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.18300000000605E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.118030E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.2263999999449E-06 |
| Normal-VS-Type2 PRCC |
9.276200E-01 |
| Normal-VS-KIRP CIMP |
1.002380E-02 |
| Normal-VS-Unclassified PRCC |
1.048190E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.012600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.002500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.575200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.35079999999699E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.509000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.982600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.588600E-01 |
| Normal-vs-N1 |
1.329150E-01 |
| Normal-vs-N2 |
4.186600E-01 |
| N0-vs-N1 |
6.288100E-02 |
| N0-vs-N2 |
1.025200E-01 |
| N1-vs-N2 |
7.516400E-01 |
|
|
